Vaginal suppositories containing Lactobacillus acidophilus: development and characterization. 2015

Francisca Rodrigues, and Maria João Maia, and José das Neves, and Bruno Sarmento, and Maria Helena Amaral, and Maria Beatriz P P Oliveira
a Department of Chemical Sciences , Faculty of Pharmacy, REQUIMTE .

OBJECTIVE The aim of this study was to develop and characterize suppositories for vaginal delivery of Lactobacillus acidophilus. METHODS Formulations were performed in order to select suitable excipients based on suppository formation feasibility and cytotoxicity. Solid body and hollow-type suppositories were prepared by melting and molding using poly(ethylene glycol) (PEG) 400 and 4000 or Witepsol (WIT) H12 as excipients. L. acidophilus was incorporated in the molten mass before molding solid body suppositories or added as suspension into the cavity of hollow-type suppositories and sealed molten excipients. Cytotoxicity of the selected excipients was evaluated by 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium and lactate dehydrogenase assays against VK2/E6E7, HEC-1-A and HeLa cells. Suppositories were characterized regarding organoleptic characteristics, mass uniformity, disintegration, breaking strength and L. acidophilus in vitro release. RESULTS PEG 400, PEG 4000 and WIT H12 showed the absence of toxicity when tested using three different vaginal cell lines. Obtained vaginal suppositories presented uniform and mild texture, a content of about 1 × 10(8) colony-forming units, completely disintegrated in simulated vaginal environment in less than 60 min and provided sustained in vitro release of L. acidophilus. Release studies further demonstrated that incorporation of freeze-dried bacteria did not result in significant loss of viable bacteria, thus supporting that vaginal suppositories may possess good properties to promote the replacement of the vaginal flora in situations of urinary tract infection. CONCLUSIONS Hollow-type suppositories showed to be promising delivery vehicles for vaginal delivery of probiotics.

UI MeSH Term Description Entries
D007779 Lactobacillus acidophilus A species of gram-positive, rod-shaped bacteria isolated from the intestinal tract of humans and animals, the human mouth, and vagina. This organism produces the fermented product, acidophilus milk. Lactobacillus amylovorus
D011092 Polyethylene Glycols Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS. Macrogols,Polyoxyethylenes,Carbowax,Macrogol,Polyethylene Glycol,Polyethylene Oxide,Polyethyleneoxide,Polyglycol,Glycol, Polyethylene,Glycols, Polyethylene,Oxide, Polyethylene,Oxides, Polyethylene,Polyethylene Oxides,Polyethyleneoxides,Polyglycols,Polyoxyethylene
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002626 Chemistry, Pharmaceutical Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use. Medicinal Chemistry,Chemistry, Pharmaceutic,Pharmaceutic Chemistry,Pharmaceutical Chemistry,Chemistry, Medicinal
D005079 Excipients Usually inert substances added to a prescription in order to provide suitable consistency to the dosage form. These include binders, matrix, base or diluent in pills, tablets, creams, salves, etc. Excipient,Stabilizing Agent,Stabilizing Agents,Suspending Agent,Suspending Agents,Agent, Stabilizing,Agent, Suspending,Agents, Stabilizing,Agents, Suspending
D005260 Female Females
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000282 Administration, Intravaginal The insertion of drugs into the vagina to treat local infections, neoplasms, or to induce labor. The dosage forms may include medicated pessaries, irrigation fluids, and suppositories. Administration, Vaginal,Drug Administration, Vaginal,Instillation, Vaginal,Intravaginal Administration,Vaginal Drug Administration,Vaginal Administration,Administration, Vaginal Drug,Administrations, Intravaginal,Administrations, Vaginal,Administrations, Vaginal Drug,Drug Administrations, Vaginal,Instillations, Vaginal,Intravaginal Administrations,Vaginal Administrations,Vaginal Drug Administrations,Vaginal Instillation,Vaginal Instillations
D013488 Suppositories Medicated dosage forms that are designed to be inserted into the rectal, vaginal, or urethral orifice of the body for absorption. Generally, the active ingredients are packaged in dosage forms containing fatty bases such as cocoa butter, hydrogenated oil, or glycerogelatin that are solid at room temperature but melt or dissolve at body temperature. Rectal Suppositories,Vaginal Suppositories,Vaginal Suppository,Suppositories, Rectal,Suppositories, Vaginal,Suppository, Vaginal

Related Publications

Francisca Rodrigues, and Maria João Maia, and José das Neves, and Bruno Sarmento, and Maria Helena Amaral, and Maria Beatriz P P Oliveira
May 1995, Journal of clinical microbiology,
Francisca Rodrigues, and Maria João Maia, and José das Neves, and Bruno Sarmento, and Maria Helena Amaral, and Maria Beatriz P P Oliveira
January 2012, TheScientificWorldJournal,
Francisca Rodrigues, and Maria João Maia, and José das Neves, and Bruno Sarmento, and Maria Helena Amaral, and Maria Beatriz P P Oliveira
June 2017, International journal of immunopathology and pharmacology,
Francisca Rodrigues, and Maria João Maia, and José das Neves, and Bruno Sarmento, and Maria Helena Amaral, and Maria Beatriz P P Oliveira
January 1975, Farmatsiia,
Francisca Rodrigues, and Maria João Maia, and José das Neves, and Bruno Sarmento, and Maria Helena Amaral, and Maria Beatriz P P Oliveira
June 2009, Applied and environmental microbiology,
Francisca Rodrigues, and Maria João Maia, and José das Neves, and Bruno Sarmento, and Maria Helena Amaral, and Maria Beatriz P P Oliveira
November 2023, International urogynecology journal,
Francisca Rodrigues, and Maria João Maia, and José das Neves, and Bruno Sarmento, and Maria Helena Amaral, and Maria Beatriz P P Oliveira
August 1982, Die Pharmazie,
Francisca Rodrigues, and Maria João Maia, and José das Neves, and Bruno Sarmento, and Maria Helena Amaral, and Maria Beatriz P P Oliveira
December 1992, Annals of allergy,
Francisca Rodrigues, and Maria João Maia, and José das Neves, and Bruno Sarmento, and Maria Helena Amaral, and Maria Beatriz P P Oliveira
June 1963, Clinical medicine (Northfield, Ill.),
Francisca Rodrigues, and Maria João Maia, and José das Neves, and Bruno Sarmento, and Maria Helena Amaral, and Maria Beatriz P P Oliveira
April 1996, The new microbiologica,
Copied contents to your clipboard!